Local Institution - 102

New York, New York 10065

0 studies enrolling now · 2 studies all time

What they study most

Leukemia, Myeloid, Multiple Myeloma

Studies at this site

• Study of CC-96191 in Participants With Relapsed or Refractory Acute Myeloid Leukemia — Stopped early
• A Study of CC-98633, BCMA-targeted Chimeric Antigen Receptor (CAR) T Cells, in Participants With Relapsed and/or Refractory Multiple Myeloma — Completed